1. Aaberge IS, Eng J, Lermark G. Lvik M (1995) Virulence of Streptococcus pneumoniaein mice:a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb Pathog 18:141–152
2. Aeberge IS, Hvalbye B, Lvik M (1996) Enhancement of Streptococcus pneumoniaeserotype 6B infection in mice after passive immunization with human serum. Microb Pathog 21:125–137
3. Åhman F, Käyhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J (1996a) Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 15:134–139
4. Åhman F, Käyhty H, Leroy O, Eskola J (1996b) Booster responses to polysaccharide vaccine at 14 months after immunisation with tetravalent pneumococcal (Pnc) conjugate vaccine PncT in infancy is dose dependent (abstact G109). In:Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, 15–18 September
5. Åhman F, Kayhty H, Leroy O, Froeschle J, Eskola J (1996c) Booster responses to polysaccharide and conjugate vaccine at 14 months after immunisation with tetravalent pneumococcal conjugate vaccine PncD in infancy (abstract Gl10). In:Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, 15–18 September